{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:15:30Z","timestamp":1792678530388,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"vor","delay-in-days":415,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SA1940\/2-1"],"award-info":[{"award-number":["SA1940\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG045044"],"award-info":[{"award-number":["R01AG045044"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56AI104234"],"award-info":[{"award-number":["R56AI104234"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["652745"],"award-info":[{"award-number":["652745"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.chembiol.2016.09.016","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T13:47:04Z","timestamp":1478180824000},"page":"1407-1416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection"],"prefix":"10.1016","volume":"23","author":[{"given":"Sharavathi\u00a0Guddehalli","family":"Parameswarappa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Reppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Geissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"M\u00e9nov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramanian","family":"Govindan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam\u00a0D.J.","family":"Calow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Wahlbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus\u00a0W.","family":"Weishaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bopanna\u00a0Ponnappa","family":"Monnanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland\u00a0Lawrence","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liise-Anne","family":"Pirofski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif\u00a0Erik","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claney\u00a0Lebev","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakkumkal","family":"Anish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter\u00a0H.","family":"Seeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2016.09.016_bib1","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1002\/anie.201301633","article-title":"Plague detection by anti-carbohydrate antibodies","volume":"52","author":"Anish","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.chembiol.2016.09.016_bib2","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1021\/cb400602k","article-title":"Immunogenicity and diagnostic potential of synthetic antigenic cell surface glycans of leishmania","volume":"8","author":"Anish","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chembiol.2014.01.002","article-title":"Chemical biology approaches to designing defined carbohydrate vaccines","volume":"21","author":"Anish","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrd3012","article-title":"Carbohydrate vaccines: developing sweet solutions to sticky situations?","volume":"9","author":"Astronomo","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2016.09.016_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1084\/jem.54.3.437","article-title":"Chemo-immunological studies on conjugated carbohydrate-proteins. V. The immunological specificity of an antigen prepared by combining the capsular polysaccharide of type III pneumococcus with foreign protein","volume":"54","author":"Avery","year":"1931","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.chembiol.2016.09.016_bib6","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/IAI.69.7.4698-4701.2001","article-title":"Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM197 conjugates induce protection against Streptococcus pneumoniae type 3 in mice","volume":"69","author":"Benaissa-Trouw","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chembiol.2016.09.016_bib7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1021\/ol025644l","article-title":"Preparation of substituted piperazinones via tandem reductive amination-(N,N\u2032-acyl transfer)-cyclization","volume":"4","author":"Beshore","year":"2002","journal-title":"Org. Lett."},{"key":"10.1016\/j.chembiol.2016.09.016_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri3167","article-title":"Beyond pattern recognition: five immune checkpoints for scaling the microbial threat","volume":"12","author":"Blander","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib9","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4049\/jimmunol.125.4.1499","article-title":"Regulation of thymus-independent responses: unresponsiveness to a second challenge of TNP-Ficoll is mediated by hapten-specific antibodies","volume":"125","author":"Brodeur","year":"1980","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/CMR.00012-08","article-title":"Animal models of Streptococcus pneumoniae disease","volume":"21","author":"Chiavolini","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.chembiol.2016.09.016_bib11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1165\/rcmb.2014-0052MA","article-title":"Miniaturized bronchoscopy enables unilateral investigation, application, and sampling in mice","volume":"51","author":"Dames","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/07328309708007324","article-title":"Synthesis of a single repeat unit of type VIII group B streptococcus capsular polysaccharide 1","volume":"16","author":"Eichler","year":"1997","journal-title":"J.\u00a0Carbohydr. Chem."},{"key":"10.1016\/j.chembiol.2016.09.016_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997","volume":"90","author":"Feikin","year":"2000","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.chembiol.2016.09.016_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cbpa.2013.11.013","article-title":"Glycan arrays as tools for infectious disease research","volume":"18","author":"Geissner","year":"2014","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/acschembio.5b00768","article-title":"Deciphering antigenic determinants of Streptococcus pneumoniae serotype 4 capsular polysaccharide using synthetic oligosaccharides","volume":"11","author":"Geissner","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib16","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/CVI.05252-11","article-title":"Establishment of a new human pneumococcal standard reference serum, 007sp","volume":"18","author":"Goldblatt","year":"2011","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2012.06673.x","article-title":"Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine","volume":"1263","author":"Gruber","year":"2012","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.chembiol.2016.09.016_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/07328309308018993","article-title":"Synthesis of a site-specific deuterium\u00a0substituted methyl \u03b2-D-glucan decasaccharide","volume":"12","author":"H\u00e4llgren","year":"1993","journal-title":"J.\u00a0Carbohydr. Chem."},{"key":"10.1016\/j.chembiol.2016.09.016_bib19","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chembiol.2016.09.016_bib20","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1128\/IAI.67.8.4128-4133.1999","article-title":"Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections","volume":"67","author":"Jakobsen","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chembiol.2016.09.016_bib21","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/IAI.67.11.5892-5897.1999","article-title":"Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections","volume":"67","author":"Jakobsen","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chembiol.2016.09.016_bib22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1128\/IAI.69.2.787-793.2001","article-title":"Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B- specific epitopes that elicit protective antibodies in mice","volume":"69","author":"Jansen","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chembiol.2016.09.016_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/314845","article-title":"Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae","volume":"180","author":"Johnson","year":"1999","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chembiol.2016.09.016_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0264-410X(96)00148-X","article-title":"The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity","volume":"15","author":"Laferri\u00e8re","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.chembiol.2016.09.016_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.carres.2008.12.014","article-title":"Synthesis of the \u03b2-1,3-glucan, laminarahexaose: NMR and conformational studies","volume":"344","author":"Mo","year":"2009","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.chembiol.2016.09.016_bib27","doi-asserted-by":"crossref","first-page":"20488","DOI":"10.1038\/srep20488","article-title":"Cross reactive material 197 glycoconjugate vaccines contain privileged conjugation sites","volume":"6","author":"M\u00f6ginger","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chembiol.2016.09.016_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0952-7915(95)80109-X","article-title":"T cell independent antigens","volume":"7","author":"Mond","year":"1995","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.vaccine.2014.11.026","article-title":"Carrier priming with CRM197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation","volume":"33","author":"Pecetta","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.chembiol.2016.09.016_bib30","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.vaccine.2016.03.055","article-title":"Carrier priming effect of CRM197 is related to an enhanced B and T\u00a0cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM197 and diphtheria toxoid","volume":"34","author":"Pecetta","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.chembiol.2016.09.016_bib31","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1002\/anie.201504847","article-title":"Chemical synthesis elucidates the immunological importance of a pyruvate modification in the capsular polysaccharide of Streptococcus pneumoniae serotype 4","volume":"54","author":"Pereira","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.chembiol.2016.09.016_bib32","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4049\/jimmunol.176.3.1686","article-title":"Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine","volume":"176","author":"Phalipon","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijantimicag.2008.01.021","article-title":"Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species","volume":"32","author":"Pletz","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.chembiol.2016.09.016_bib34","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.vaccine.2009.03.017","article-title":"Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics","volume":"27","author":"Poolman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.chembiol.2016.09.016_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0065-2318(01)56004-7","article-title":"Oligosaccharide-protein conjugates as vaccine candidates against bacteria","volume":"56","author":"Pozsgay","year":"2000","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"10.1016\/j.chembiol.2016.09.016_bib36","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/erv.09.113","article-title":"10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix\u2122","volume":"8","author":"Prymula","year":"2014","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.chembiol.2016.09.016_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chembiol.2014.11.016","article-title":"Antigenic potential of a highly conserved Neisseria meningitidis lipopolysaccharide inner core structure defined by chemical synthesis","volume":"22","author":"Reinhardt","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib38","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1165\/rcmb.2008-0071OC","article-title":"Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia","volume":"40","author":"Reppe","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CVI.13.2.165-169.2006","article-title":"Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines","volume":"13","author":"Romero-Steiner","year":"2006","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib40","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1128\/IAI.00472-08","article-title":"Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14","volume":"76","author":"Safari","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chembiol.2016.09.016_bib41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/bies.201200057","article-title":"Improved vaccines through targeted manipulation of the body's immunological risk-assessment?","volume":"34","author":"Sander","year":"2012","journal-title":"Bioessays"},{"key":"10.1016\/j.chembiol.2016.09.016_bib42","doi-asserted-by":"crossref","first-page":"53241","DOI":"10.1074\/jbc.M313702200","article-title":"Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor","volume":"279","author":"Schmeck","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2016.09.016_bib43","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1128\/CVI.05313-11","article-title":"Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption","volume":"18","author":"Schuerman","year":"2011","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib44","series-title":"Biotherapeutics","first-page":"68","article-title":"CHAPTER 3. Carbohydrate vaccines","author":"Schumann","year":"2013"},{"key":"10.1016\/j.chembiol.2016.09.016_bib45","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1128\/iai.40.3.856-861.1983","article-title":"Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3","volume":"40","author":"Snippe","year":"1983","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chembiol.2016.09.016_bib46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10156-013-0601-1","article-title":"Pneumococcal vaccine and opsonic pneumococcal antibody","volume":"19","author":"Song","year":"2013","journal-title":"J.\u00a0Infect. Chemother."},{"key":"10.1016\/j.chembiol.2016.09.016_bib47","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/iai.32.2.490-496.1981","article-title":"Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice","volume":"32","author":"Svenson","year":"1981","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chembiol.2016.09.016_bib48","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1128\/IAI.01075-08","article-title":"Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice","volume":"77","author":"Tian","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chembiol.2016.09.016_bib49","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1016\/j.vaccine.2013.07.078","article-title":"Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines","volume":"31","author":"Tontini","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.chembiol.2016.09.016_bib50","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1002\/anie.201302540","article-title":"Synthesis of Neisseria meningitidis serogroup W135 capsular oligosaccharides for immunogenicity comparison and vaccine development","volume":"52","author":"Wang","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.chembiol.2016.09.016_bib51","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3762\/bjoc.12.139","article-title":"Automated glycan assembly of a S.\u00a0pneumoniae serotype 3 CPS antigen","volume":"12","author":"Weishaupt","year":"2016","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.chembiol.2016.09.016_bib52","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1097\/01.CCM.0000220496.48295.A9","article-title":"Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia","volume":"34","author":"Witzenrath","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.chembiol.2016.09.016_bib53","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4049\/jimmunol.1003143","article-title":"The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia","volume":"187","author":"Witzenrath","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib54","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization\u2013WHO position paper","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.chembiol.2016.09.016_bib55","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/INF.0b013e3182615615","article-title":"Evolving picture of\u00a0invasive pneumococcal disease in Massachusetts children: a comparison of disease in 2007-2009 with earlier periods","volume":"31","author":"Yildirim","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.chembiol.2016.09.016_bib56","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.micro.62.081307.162944","article-title":"Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation","volume":"65","author":"Yother","year":"2011","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.chembiol.2016.09.016_bib57","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1016\/j.tetlet.2003.09.230","article-title":"An efficient method for the preparation of glycosides with a free C-2 hydroxyl group from thioglycosides","volume":"44","author":"Yu","year":"2003","journal-title":"Tetrahedron Lett."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945616303567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945616303567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:32:31Z","timestamp":1762525951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945616303567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2451945616303567"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2016.09.016","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2016.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}